Oct 14 (Reuters) - H Lundbeck A/S has agreed
to buy US-based Longboard Pharmaceuticals ( LBPH ) in a $2.6
billion deal to boost its pipeline of treatments for neuro-rare
conditions, the companies said on Monday.
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini
Ganguli)